Aramark (ARMK) Stock Price & Analysis
Aramark (ARMK) closed at USD 52.52 on Thursday, October 22, 2026, down 5.73% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 52.52; the Oct 22, 2026 session ranged USD 52.21–55.8 on volume of 4,488,092 shares. Market capitalization is —, with a 52-week range of USD 35.07–62.65 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 12:06 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ARMK.md
Key facts (ARMK)
- Last four reported quarters (through Jul 3, 2026): revenue $19.8B, net income $383M (1.9% margin), free cash flow $433M (SEC filings).
- 1 of 80 tracked superinvestors hold ARMK (13F, Q2 2026): 0 new, 1 added, 0 reduced, 0 unchanged.
- Total return with dividends: 1Y +33.1% vs S&P 500 +14.9%; 5Y +110.0% vs S&P 500 +80.3%.
- Next earnings: 2026-11-16, EPS estimate USD 0.75, revenue estimate $5.29B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (ARMK)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $12.1B | $13.7B | $16.1B | $17.4B | $18.5B | $19.8B |
| Gross profit | $1.09B | -$1.08B | — | — | — | — |
| Operating income | $191M | $415M | $625M | $707M | $792M | $871M |
| Net income | -$90.8M | $194M | $674M | $263M | $326M | $383M |
| EPS (diluted) | -$0.36 | $0.75 | $2.57 | $0.99 | $1.22 | — |
| Free cash flow | $249M | $383M | $383M | $299M | $432M | $433M |
| Gross margin | 9.0% | -7.9% | — | — | — | — |
| Operating margin | 1.6% | 3.0% | 3.9% | 4.1% | 4.3% | 4.4% |
| Net margin | -0.8% | 1.4% | 4.2% | 1.5% | 1.8% | 1.9% |
| Revenue growth | -5.7% | +13.2% | +17.5% | +8.2% | +6.4% | — |
| Cash + short-term investments | $533M | $306M | $1.93B | $672M | $639M | — |
| Total debt | $7.45B | $7.41B | $6.70B | $5.27B | $5.41B | — |
Fiscal years end Oct. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jul 3, 2026) (ARMK)
P/E at fiscal year-ends: Oct 2025 31.0x, Sep 2024 39.3x, Sep 2023 9.8x.
Superinvestors (SEC 13F-HR, Q2 2026) (ARMK)
1 of 80 tracked investors hold ARMK. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| First Eagle Investment | First Eagle Investment Management | <0.01% | $854K | Added +36.4% |
Analysts (ARMK)
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | Citigroup | Target raised | Buy | $74 → $75.5 |
| 2026-08-19 | RBC Capital | Target raised | Outperform | $60 → $70 |
| 2026-08-13 | Citigroup | Target raised | Buy | $70.5 → $74 |
| 2026-08-13 | JP Morgan | Target raised | Overweight | $55 → $70 |
| 2026-08-12 | Stifel | Target raised | Buy | $54 → $70 |
| 2026-08-12 | Jefferies | Target raised | Buy | $62 → $70 |
| 2026-08-12 | UBS | Target raised | Buy | $67 → $71 |
| 2026-08-12 | Baird | Target raised | Outperform | $63 → $69 |
| 2026-07-27 | Truist Securities | Target raised | Buy | $58 → $70 |
| 2026-06-29 | Oppenheimer | Target raised | Outperform | $60 → $65 |
Total return (dividends reinvested) (ARMK)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +33.1% | +110.0% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +33.2% | +16.0% |
| Volatility (annualized) | 26.2% | 28.5% |
| Max drawdown | -15.7% (Aug 2026→Oct 2026) | -25.5% (Jan 2023→Mar 2023) |
ARMK revenue by business segment (quarter ended Jul 3, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| FSS United States | $3.50B | 69.1% | +7.7% |
| FSS International | $1.56B | 30.9% | +13.2% |
| Total revenue | $5.06B | 100% | — |
ARMK revenue by region (fiscal year ended Oct 3, 2025)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| FSS United States: | $13.06B | 70.6% | +5.0% |
| Foreign | $5.44B | 29.4% | +9.8% |
| Total revenue | $18.51B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
ARMK suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Supplier | SYSCO CORP (SYY) | “We purchase most products and other items through food service distribution companies, including Sysco Corporation ("Sysco"), US Foods, Performance Food Group and other regional distributors.” |
Quoted from the company's 10-K filed Nov 25, 2025.
ARMK analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.75 | $0.76 | -0.6% | $5.29B | 12 |
| Next quarter (ends Dec 2026) | $0.64 | $0.62 | +2.4% | $5.28B | 10 |
| Current fiscal year (ends Sep 2026) | $2.28 | $2.25 | +1.3% | $20.11B | 15 |
| Next fiscal year (ends Sep 2027) | $2.81 | $2.69 | +4.5% | $21.89B | 15 |
ARMK options: expected move
Options price a move of about ±9.0% (±$4.72) by Nov 20, 2026, which includes earnings on Nov 16, 2026. Over the last 8 reports the stock moved ±7.2% on average.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 36.0% | ±9.0% |
| Dec 18, 2026 | 56 | 28.9% | ±9.9% |
| Jan 15, 2027 | 84 | 27.2% | ±11.2% |
| Apr 16, 2027 | 175 | 27.1% | ±15.8% |
| May 21, 2027 | 210 | 28.8% | ±18.3% |
| Aug 20, 2027 | 301 | 27.7% | ±20.8% |
| Nov 19, 2027 | 392 | 27.4% | ±23.3% |
30-day implied volatility 29.3% vs 24.9% realized over the last 30 trading days. Put/call ratio (volume) 0. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 12:06 UTC)
| Price | USD 52.52 |
|---|---|
| Change | ▼ 5.73% (down) |
| Previous Close | USD 52.52 |
| Open | USD 52.52 |
| Day Range | USD 52.21 – 55.8 |
| 52-Week Range | USD 35.07 – 62.65 |
| Volume | 4,488,092 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (ARMK)
Nexqual's technical model rates ARMK "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 12:06 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 32.26 (neutral) |
| vs SMA50 | Below (USD 56.85) |
| MACD | -0.47 (negative) |
Earnings (ARMK)
| Next Earnings Date | 2026-11-16 |
|---|---|
| EPS Estimate | USD 0.75 |
| Revenue Estimate | $5.29B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.52 vs est 0.48 ▲ beat |
| 2026-03-31 | USD 0.49 vs est 0.48 ▲ beat |
| 2025-12-31 | USD 0.51 vs est 0.51 ▲ beat |
| 2025-09-30 | USD 0.57 vs est 0.65 ▼ miss |
Source: Nexqual, October 23, 2026 at 12:06 UTC.
Financials & Fundamentals (ARMK)
| Total Revenue | $19.85B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +9.30% |
| Gross Margin | +15.29% |
| Operating Margin | +4.42% |
| Profit Margin | +1.93% |
| ROE | +11.69% |
| Debt / Equity | 1.87 |
| Current Ratio | 1.29 |
| Total Cash | $520.39M |
| Total Debt | $6.47B |
Source: Nexqual, October 23, 2026 at 12:06 UTC.
Ownership (ARMK)
| Insider Ownership | +0.65% |
|---|---|
| Institutional Ownership | +100.26% |
| Shares Outstanding | 263.63M |
| Float | 261.88M |
| Short % of Float | +2.98% |
Source: Nexqual, October 23, 2026 at 12:06 UTC.
From Aramark's Latest SEC 10-K Filing (filed 2025-11-25)
Key Strengths & Strategy (as disclosed to the SEC)
- In our FSS International segment (other than Canada), our approach to purchasing is substantially similar.
- One key effort in our approach is identifying and matching individuals at various levels in our organization with individuals in a variety of roles at both existing and potential clients.
- We believe that these connections throughout various levels within the client organization allow us to develop strong relationships with the client and gain a better understanding of the clients' requirements.
- We use contracts with our customers that allow us to manage our potential upside and downside risk in connection with our various business interactions.
Partnerships
- We have a master distribution agreement with Sysco that covers a significant amount of our purchases of products and items in the United States and another distribution agreement with Sysco that covers our purchases of products in Canada.
- On January 26, 2007, we delisted from the New York Stock Exchange ("NYSE") in conjunction with a going-private transaction executed with certain private equity investment funds, as well as approximately 250 senior management personnel.
Legal & Regulatory Risks (Item 1A, quoted)
- Laws and governmental regulations relating to food and beverages may subject us to significant liability and reputational harm.
- Changes to, new interpretations of or changes in the enforcement of the governmental regulatory framework may affect our contracts and contract terms and may reduce our revenue or profits.
- Our operations and reputation may be adversely affected by disruptions to or breaches of our information systems or if our data is otherwise compromised.
- Environmental requirements may subject us to significant liability and limit our ability to grow.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ULS | UL Solutions Inc. | USD 73.63 | ▼ 0.88% |
| RBA | RB Global, Inc. | USD 84.39 | ▲ 2.91% |
| RTO | Rentokil Initial plc | USD 22.88 | ▲ 8.75% |
| GPN | Global Payments Inc. | USD 85.88 | ▲ 2.81% |
| CPRT | Copart, Inc. | USD 29.09 | ▲ 5.44% |
| DLB | Dolby Laboratories | USD 63.28 | ▲ 1.22% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 12:06 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt